Paper33803151
The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.
Masadah R and 4 others. Cancers (Basel), 2021. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer. Papers, record 33803151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33803151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NA | Indonesia Endowment Fund for Education (LPDP) | PubMed | ||
| NA | Fondazione Italiana Fegato-ONLUS | PubMed |
Source PubMed
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18767981 | PTEN and the PI3-kinase pathway in cancer. | Annu Rev Pathol | 2009 | https://conductscience.org/library/papers/18767981 | PubMed |
| 2 | 19694703 | Osteopontin expression correlates with invasiveness in cervical cancer. | Aust N Z J Obstet Gynaecol | 2009 | https://conductscience.org/library/papers/19694703 | PubMed |
| 3 | 27354763 | Molecular mechanisms of cisplatin resistance in cervical cancer. | Drug Des Devel Ther | 2016 | https://conductscience.org/library/papers/27354763 | PubMed |
| 4 | 25324171 | Oncogenicity of LHX2 in pancreatic ductal adenocarcinoma. | Mol Biol Rep | 2014 | https://conductscience.org/library/papers/25324171 | PubMed |
| 5 | 26878391 | MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. | Oncogenesis | 2016 | https://conductscience.org/library/papers/26878391 | PubMed |
| 6 | 27904781 | MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase. | Am J Cancer Res | 2016 | https://conductscience.org/library/papers/27904781 | PubMed |
| 7 | 8463044 | Natural history of cervical intraepithelial neoplasia: a critical review. | Int J Gynecol Pathol | 1993 | https://conductscience.org/library/papers/8463044 | PubMed |
| 8 | 27040383 | Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog. | Arch Biochem Biophys | 2016 | https://conductscience.org/library/papers/27040383 | PubMed |
| 9 | 19853287 | Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study. | Gynecol Oncol | 2010 | https://conductscience.org/library/papers/19853287 | PubMed |
| 10 | 30219819 | MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30219819 | PubMed |
| 11 | 10202165 | Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10202165 | PubMed |
| 12 | 29872582 | High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/29872582 | PubMed |
| 13 | 25037503 | The pentose phosphate pathway and cancer. | Trends Biochem Sci | 2014 | https://conductscience.org/library/papers/25037503 | PubMed |
| 14 | 20065848 | Comparison between conventional surgery plus postoperative adjuvant radiotherapy and concurrent chemoradiation for FIGO stage IIB cervical carcinoma: a retrospective study. | Am J Clin Oncol | 2010 | https://conductscience.org/library/papers/20065848 | PubMed |
| 15 | 24077440 | The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer. | Reprod Sci | 2014 | https://conductscience.org/library/papers/24077440 | PubMed |
| 16 | 22287315 | Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. | J Pathol | 2012 | https://conductscience.org/library/papers/22287315 | PubMed |
| 17 | 3894589 | Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. | J Clin Oncol | 1985 | https://conductscience.org/library/papers/3894589 | PubMed |
| 18 | 32244055 | Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer. | Gene | 2020 | https://conductscience.org/library/papers/32244055 | PubMed |
| 19 | 31190335 | miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51. | J Cell Physiol | 2020 | https://conductscience.org/library/papers/31190335 | PubMed |
| 20 | 29099271 | SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell. | Cell Cycle | 2018 | https://conductscience.org/library/papers/29099271 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903611 | Chemoresistance in cervical cancer: identifying and exploiting non-coding RNAs. | Front Oncol | 2026 | https://conductscience.org/library/papers/42903611 | PubMed |
| 42668735 | A comprehensive review on apoptotic miRNAs and antagomiRs in breast cancer: Enhancing radio sensitization. | Genes Dis | 2026 | https://conductscience.org/library/papers/42668735 | PubMed |
| 42363253 | Decoding the association between platinum resistance and HPV status in cervical cancer using organoid models. | BMC Biol | 2026 | https://conductscience.org/library/papers/42363253 | PubMed |
| 41113473 | LncRNA-EME1 enhances BRCA1 recruitment and alters repair of DNA damage in cervical cancer radioresistance. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/41113473 | PubMed |
| 40641137 | MicroRNAs: Novel clinical biomarkers for cancer radiotherapy (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40641137 | PubMed |
| 40534305 | Hsa_circ_0101308 adjusted by N6-methyladenosine (m6A) impacts chemo-resistance in cervical cancer via sponging miR-224. | Cancer Biomark | 2025 | https://conductscience.org/library/papers/40534305 | PubMed |
| 40358898 | Interplay between NETosis and the lncRNA-microRNA regulatory axis in the immunopathogenesis of cancer. | J Physiol Biochem | 2025 | https://conductscience.org/library/papers/40358898 | PubMed |
| 40076427 | Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076427 | PubMed |
| 39346724 | Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin. | Front Oncol | 2024 | https://conductscience.org/library/papers/39346724 | PubMed |
| 39263322 | Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39263322 | PubMed |
| 39147708 | [Research Progress of Engineered Exosomes in the Treatment of Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2024 | https://conductscience.org/library/papers/39147708 | PubMed |
| 38327905 | Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38327905 | PubMed |
| 38067329 | The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38067329 | PubMed |
| 37804407 | Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach. | Mol Biotechnol | 2024 | https://conductscience.org/library/papers/37804407 | PubMed |
| 37593506 | Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression. | Iran J Public Health | 2023 | https://conductscience.org/library/papers/37593506 | PubMed |
| 37140697 | BRSK1 confers cisplatin resistance in cervical cancer cells via regulation of mitochondrial respiration. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37140697 | PubMed |
| 36922504 | Engineered exosomes from different sources for cancer-targeted therapy. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36922504 | PubMed |
| 36875073 | Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. | Front Immunol | 2023 | https://conductscience.org/library/papers/36875073 | PubMed |
| 36793374 | Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells. | J Oncol | 2023 | https://conductscience.org/library/papers/36793374 | PubMed |
| 36632741 | Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1. | Cancer Sci | 2023 | https://conductscience.org/library/papers/36632741 | PubMed |
Genes74
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33803151
GET https://conductscience.org/api/papers/v1/33803151/references?page=2